Should you buy INMB stock?

Last updated:

Based on market data through , StockInvest.us rates Inmune (INMB) as a Strong Buy Candidate with a technical score of 7.51 on its -10 to +10 scale. This is an upgrade from Buy in the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 44.14%
  • 3-month trend forecast Up 39.96%
  • Strong Buy Candidate 7.51
AI Analysis AI Analysis of INMB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add INMB to Watchlist?
Some Reasons Why To Add INMB:
  • Consistently positive technical signals over the last month
  • Highly efficient cash conversion (107% FCF/OCF ratio)
  • Lower volatility than the market (beta 0.98)
PDF

Inmune stock price up more than 9.42% on Friday
(Market data through Aug 07, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 18, 2026 Gain 44.14%

The Inmune stock price gained 9.42% on the last trading day (Friday, 7th Aug 2026), rising from $1.91 to $2.09. During the last trading day the stock fluctuated 9.90% from a day low at $1.92 to a day high of $2.11. The price has risen in 6 of the last 10 days and is up by 29.01% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 708 thousand more shares were traded than the day before. In total, 953 thousand shares were bought and sold for approximately $1.99 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 39.96% during the next 3 months and, with a 90% probability hold a price between $2.41 and $3.13 at the end of this 3-month period.

INMB Signals & Forecast

The Inmune stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.88 and $1.75. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, July 24, 2026, and so far it has risen 29.01%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Inmune stock

Inmune finds support from accumulated volume at $2.07 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.190 between high and low, or 9.90%. For the last week, the stock has had daily average volatility of 7.68%.

Our recommended stop-loss: $2.01 (-3.90%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (INMB) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect Inmune Bio Inc. to open at $2.04, and during the day (based on 14 day Average True Range), to move between $2.02 and $2.16, which gives a possible trading interval of +/-$0.137 (+/-6.80%) up or down from last closing price. If Inmune Bio Inc. takes out the full calculated possible swing range there will be an estimated 6.80% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $2.07, some $0.0200 (0.96%) from the current price of $2.09, our system finds the risk reward attractive.

Is Inmune Bio Inc. stock A Buy?

Inmune holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 7.509 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $2.04 ( 2.39%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

INMB Performance

Trading levels for INMB

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.23 6.70%
R2 2.16 3.23%
R1 2.11 1.08%
Price 2.09
S1 1.97 -5.87%
S2 1.92 -8.01%
S3 1.85 -11.48%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 2.09
S1 2.07 -0.96%
S2 1.74 -16.75%
S3 1.68 -19.62%

FAQ

What is the symbol for Inmune Stock and on which exchange is it traded?
The symbol for Inmune is INMB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Inmune Stock?
Based on market data through Aug 07, 2026, StockInvest.us rates Inmune (INMB) as a Strong Buy Candidate with a technical score of 7.51 on its -10 to +10 scale. This is an upgrade from Buy in the previous daily evaluation. Since the Buy signal began on Jun 18, 2026, the price has risen 44.14%. The current 3-month trend forecast projects a rise of 39.96%.

How to buy Inmune Stock?
Inmune Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Inmune Stock.

What's the current price of Inmune Stock?
As of the end of day on the Aug 07, 2026, the price of an Inmune (INMB) share was $2.09.

What is the 52-week high and low for Inmune Stock?
The 52-week high for Inmune Stock is $2.85 and the 52-week low is $1.09.

What is the market capitalization of Inmune Stock?
As of the Aug 07, 2026, the market capitalization of Inmune is 55.43M.

When is the next earnings date for Inmune?
The upcoming earnings date for Inmune is Nov 04, 2026.
Click to get the best stock tips daily for free!
ABOUT INMUNE BIO INC.
Inmune
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic synd...
GOLDEN STAR
Ticker Change Signal Date
BIIB
$202.19
2.84% Jul 24
TSCO
$30.32
13.98% Jul 23
N
NVDU
$126.01
15.08% Jul 21
ROP
$331.60
21.31% Jun 24
TTEK
$28.04
26.39% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE